Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sharma, Gayatri | Mirza, Sameer | Yang, Yi-Hsin; | Parshad, Rajinder | Hazrah, Priya | Datta Gupta, Siddartha | Ralhan, Ranju;
Affiliations: Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India | Department of Surgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India | Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India | Department of Oral Hygiene, Kaohsiung Medical University, Kaohsiung, Taiwan | Division of Statistical Analysis, Department of Clinical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Note: [] Corresponding author: Ranju Ralhan, Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex, 600 University Avenue, Room 6-500, Toronto, ON, Canada M5G 1X5. Tel.: +1 416 586 4800 × 6426; Fax: +1 416 586 8628; E-mails: [email protected]; [email protected].
Abstract: Background: Methylation-mediated suppression of detoxification, DNA repair and tumor suppressor genes has been implicated in cancer development. This study was designed to investigate the impact of concurrent methylation of multiple genes in breast tumors on disease prognosis. Methods: Methylation specific PCR was carried out to analyze the methylation status of seven genes in archived breast tissues and determine the effect of aberrant methylation of multiple genes on disease prognosis and patients' survival. Results: Promoter hypermethylation was observed in PRB 67%, ERα 64%, RASSF1A 63%, p16INK4A 51%, RARβ2 22%, GSTP1 25% and BRCA1 27% of the breast cancers, respectively. Concurrent methylation of BRCA1, ERα, GSTP1 and RARβ2, was observed in a large proportion of breast cancers analyzed, suggesting that these genes do not appear to be methylated alone. Patients with high methylation indices had poor prognosis (p<0.001, Hazards ratio=14.58). Cox regression analysis showed RARβ2 promoter methylation to be an independent important determinant of breast cancer prognosis. Conclusion: Our results suggest that methylation of multiple genes plays an important role in prognosis of breast cancer. Our study not only describes the association of methylation mediated silencing of multiple genes with the severity of disease, but also drives to speculate the molecular crosstalk between genes or genetic pathways regulated by them individually.
Keywords: Breast cancer, methylation, prognosis, RARβ, GSTP1, BRCA1
DOI: 10.3233/CLO-2009-0507
Journal: Analytical Cellular Pathology, vol. 31, no. 6, pp. 487-500, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]